180 Life Sciences Corp (ATNF)

Sector:
FINANCE
Industry:
CORPORATE FINANCE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Jim Woody
Employees:
0
150 WEST 56TH STREET SUITE 5901, NEW YORK, NY 10019
212-319-5555

180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease – inflammation. The company is driving groundbreaking study into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The company’s primary platform is a novel program to treat fibrosis and inflammation using anti-TNF, with its lead program in phase 2b/3 clinical trial.

Data derived from most recent annual or quarterly report
Market Cap 86.062 Million Shares Outstanding34.016 Million Avg 30-day Volume 478.367 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0.56
Price to Revenue0.0 Debt to Equity0.2011 EBITDA-20.974 Million
Price to Book Value3.0595 Operating Margin0.0 Enterprise Value125.681 Million
Current Ratio EPS Growth-33.857 Quick Ratio
1 Yr BETA 2.4231 52-week High/Low 13.05 / 2.25 Profit Margin0.0
Operating Cash Flow Growth-320.4926 Altman Z-Score Free Cash Flow to Firm 52.807 Million
View SEC Filings from ATNF instead.

View recent insider trading info

Funds Holding ATNF (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ATNF BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

122.3 Thousand total shares from 12 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RAY RUSSELL T

  • Director
4,728 2022-01-14 3

GOLD LAWRENCE MARSHALL

  • Director
11,458 2022-01-14 3

MARRONE PAMELA G

  • Director
3,467 2022-01-14 4

MCGOVERN JR. DONALD A.

  • Director
38,178 2022-01-14 4

VU QUAN ANH COO / CHIEF BUSINESS OFFICER

  • Officer
20,500 2021-12-16 4

PAMIR OZAN INTERIM CFO

  • Officer
76,408 2021-12-10 2

WOODY JAMES N. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
37,752 2021-12-09 2

DELUCA TERESA

  • Director
12,500 2021-12-09 3

STEINMAN LAWRENCE

  • Director
627,574 2021-12-08 3

FELDMANN MARC

  • Director
5,594,860 2021-12-08 3

ROTHBARD JONATHAN B. CHIEF SCIENTIFIC OFFICER

  • Officer
860,449 2021-12-08 2

FRANCIS KNUETTEL II

  • Director
79,000 2021-08-04 2

KRAUSS MARLENE

KBL IV SPONSOR LLC

  • 10% Owner
2,353,569 2020-12-14 0

BARKER RICHARD W

  • Director
0 2020-12-03 0

SHENDELMAN SHOSHANA

  • Director
0 2020-11-06 0

OXFORD ASSET MANAGEMENT LLP

  • 10% Owner
No longer subject to file 2019-10-09 0

MIZUHO SECURITIES USA LLC

  • 10% Owner
964,000 2019-08-12 0

WEISS ASSET MANAGEMENT LP

WEISS ANDREW M

WAM GP LLC

  • 10% Owner
No longer subject to file 2019-06-05 0

POLAR ASSET MANAGEMENT PARTNERS INC.

  • 10% Owner
No longer subject to file 2019-03-06 0

KRAUSS MARLENE CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
2,875,000 2017-06-01 0

HORNIG GEORGE R

  • Director
0 2017-06-01 0

NEFF P SHERRILL

  • Director
0 2017-06-01 0

WILLIAMSON JOSEPH CHIEF OPERATING OFFICER

  • Officer
  • Director
0 2017-06-01 0

SHERMAN ANDREW

  • Director
0 2017-06-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MARRONE PAMELA G - Director

2022-01-18 16:31:47 -0500 2022-01-14 A 2,467 $3.04 a 3,467 direct -10.19 0.0 1 -10.19 2

GOLD LAWRENCE MARSHALL - Director

2022-01-18 16:32:40 -0500 2022-01-14 A 4,728 $3.04 a 11,458 direct -10.19 0.0 1 -10.19 2

MCGOVERN JR. DONALD A. - Director

2022-01-18 16:30:37 -0500 2022-01-14 A 5,550 $3.04 a 38,178 direct -10.19 0.0 1 -10.19 2

RAY RUSSELL T - Director

2022-01-18 16:33:50 -0500 2022-01-14 A 4,728 $3.04 a 4,728 direct -10.19 0.0 1 -10.19 2

VU QUAN ANH - Officer COO / CHIEF BUSINESS OFFICER

2021-12-16 17:00:10 -0500 2021-12-16 P 8,000 $3.98 a 20,500 direct -5.2632 -8.4668 0.0 1 -8.4668 6

VU QUAN ANH - Officer COO / CHIEF BUSINESS OFFICER

2021-12-10 18:04:31 -0500 2021-12-10 P 4,500 $3.90 a 12,500 direct 3.0534 5.3435 11.1959 5 0.0 1

PAMIR OZAN - Officer INTERIM CFO

2021-12-13 08:31:58 -0500 2021-12-10 P 3,800 $3.87 a 76,408 direct 3.0534 5.3435 11.1959 5 0.0 1

MARRONE PAMELA G - Director

2021-12-10 18:39:32 -0500 2021-12-10 P 1,000 $4.10 a 1,000 direct 3.0534 5.3435 11.1959 5 0.0 1

MCGOVERN JR. DONALD A. - Director

2021-12-09 21:58:55 -0500 2021-12-09 P 25,000 $4.13 a 32,628 direct -3.4398 7.371 -37.8378 7.371 6 -37.8378 31

DELUCA TERESA - Director

2021-12-13 08:35:21 -0500 2021-12-09 P 5,000 $4.00 a 5,000 direct 3.0534 5.3435 11.1959 5 0.0 1

DELUCA TERESA - Director by spouse

2021-12-13 08:35:21 -0500 2021-12-09 P 2,500 $3.95 a 2,500 indirect 3.0534 5.3435 11.1959 5 0.0 1

STEINMAN LAWRENCE - Director

2021-12-10 08:22:39 -0500 2021-12-09 P 5,000 $4.27 a 602,574 direct -3.4398 7.371 -37.8378 7.371 6 -37.8378 31

DELUCA TERESA - Director by trust

2021-12-13 08:35:21 -0500 2021-12-09 P 2,500 $3.99 a 2,500 indirect 3.0534 5.3435 11.1959 5 0.0 1

FELDMANN MARC - Director

2021-12-13 16:18:55 -0500 2021-12-09 P 50,000 $4.07 a 2,809,930 direct 0.4938 3.2099 7.9012 4 -2.2222 3

WOODY JAMES N. - Director - Officer CHIEF EXECUTIVE OFFICER

2021-12-10 08:24:31 -0500 2021-12-09 P 12,500 $4.27 a 37,752 direct -3.4398 7.371 -37.8378 7.371 6 -37.8378 31

DELUCA TERESA - Director by trust

2021-12-13 08:35:21 -0500 2021-12-09 P 2,500 $3.98 a 2,500 indirect 3.0534 5.3435 11.1959 5 0.0 1

STEINMAN LAWRENCE - Director

2021-12-10 08:22:39 -0500 2021-12-08 A 25,000 a 25,000 direct

FELDMANN MARC - Director

2021-12-13 16:18:55 -0500 2021-12-08 A 25,000 a 25,000 direct

ROTHBARD JONATHAN B. - Officer CHIEF SCIENTIFIC OFFICER

2021-12-10 16:30:28 -0500 2021-12-08 A 300,000 a 300,000 direct

VU QUAN ANH - Officer COO / CHIEF BUSINESS OFFICER

2021-12-10 08:20:48 -0500 2021-12-08 A 275,000 a 275,000 direct

FELDMANN MARC - Director

2021-12-13 16:18:55 -0500 2021-12-08 A 5,536 $3.95 a 2,759,930 direct 0.4938 3.2099 7.9012 4 -2.2222 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
180 LIFE SCIENCES CORP ATNF 2022-01-26 22:15:03 UTC -6.7772 6.8472 600000
180 LIFE SCIENCES CORP ATNF 2022-01-26 21:45:03 UTC -6.7772 6.8472 600000
180 LIFE SCIENCES CORP ATNF 2022-01-26 21:15:03 UTC -6.7772 6.8472 600000
180 LIFE SCIENCES CORP ATNF 2022-01-26 20:45:04 UTC -6.7772 6.8472 600000
180 LIFE SCIENCES CORP ATNF 2022-01-26 20:15:03 UTC -6.7772 6.8472 600000
180 LIFE SCIENCES CORP ATNF 2022-01-26 19:45:03 UTC -6.7772 6.8472 600000
180 LIFE SCIENCES CORP ATNF 2022-01-26 19:15:04 UTC -6.7772 6.8472 600000
180 LIFE SCIENCES CORP ATNF 2022-01-26 18:45:03 UTC -6.7772 6.8472 600000
180 LIFE SCIENCES CORP ATNF 2022-01-26 18:15:04 UTC -6.7772 6.8472 600000
180 LIFE SCIENCES CORP ATNF 2022-01-26 17:45:03 UTC -6.7772 6.8472 600000
180 LIFE SCIENCES CORP ATNF 2022-01-26 17:15:03 UTC -6.7772 6.8472 600000
180 LIFE SCIENCES CORP ATNF 2022-01-26 16:45:03 UTC -6.4811 6.5511 600000
180 LIFE SCIENCES CORP ATNF 2022-01-26 16:15:03 UTC -6.4811 6.5511 600000
180 LIFE SCIENCES CORP ATNF 2022-01-26 15:45:03 UTC -6.4811 6.5511 300000
180 LIFE SCIENCES CORP ATNF 2022-01-26 15:15:03 UTC -6.4811 6.5511 300000
180 LIFE SCIENCES CORP ATNF 2022-01-26 14:45:03 UTC -6.929 6.999 300000
180 LIFE SCIENCES CORP ATNF 2022-01-26 14:15:04 UTC -6.929 6.999 250000
180 LIFE SCIENCES CORP ATNF 2022-01-26 13:45:03 UTC -6.929 6.999 250000
180 LIFE SCIENCES CORP ATNF 2022-01-26 13:15:03 UTC -6.929 6.999 250000
180 LIFE SCIENCES CORP ATNF 2022-01-26 12:45:04 UTC -6.929 6.999 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments